Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Types

    ... International Prognostic Scoring System (IPSS) The IPSS ...

    Topic section last updated 06/12/2018 - 12:54pm.

  2. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R

    ... (MDS); risk distribution according to the revised International Prognostic Scoring System (IPSS-R) was 11% very high, 18% high, 17% ...

    Research Article last updated 09/18/2017 - 11:05am.

  3. A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

    ... Intermediate 1 (INT-1) or higher risk MDS defined by International Prognostic Scoring System (IPSS) criteria. More or equal than 18 years ...

    Clinical Trial last updated 05/14/2018 - 1:57pm.

  4. Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

    ... eligible patients were aged 18 years or older, had International Prognostic Scoring System -defined low or intermediate 1 risk ...

    Research Article last updated 09/18/2017 - 1:38pm.

  5. First-line Therapeutic Strategies for Myelodysplastic Syndromes.

    ... The precise diagnostic tests and subsequent prognostic stratification for patients with myelodysplastic syndrome (MDS) are ... not grounded on the available evidence. Although the International Prognostic Scoring System and revised International ...

    Research Article last updated 09/11/2017 - 8:44am.

  6. Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

    ... The Revised International Prognostic Scoring System (IPSS-R) was developed for untreated ...

    Research Article last updated 11/28/2016 - 9:42am.

  7. San Diego Family Takes Action for Awareness

    ... diagnosis of intermediate MDS, as defined by the revised International Prognostic Scoring System , also known as IPSS-R. David was only 52 at the ...

    Patient Chronicle last updated 04/26/2018 - 9:33am.

  8. Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes

    ... The revised International Prognostic Scoring System (IPSS-R) was developed in a cohort of untreated ...

    Research Article last updated 04/23/2014 - 12:10pm.

  9. A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms

    ... lower risk MDS (i.e., low or intermediate-1 risk by the International Prognostic Scoring System (IPSS)) and isolated deletion of 5q (del(5q)), ...

    Clinical Trial last updated 04/21/2018 - 6:04pm.

  10. Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

    ... The Revised International Prognostic Scoring System (IPSS-R) was developed for untreated ...

    Research Article last updated 07/18/2016 - 11:04am.